BIT
ACRS icon

BlackRock Institutional Trust’s Aclaris Therapeutics ACRS Stock Holding History

BlackRock Institutional Trust’s Portfolio ACRS Stock Details ACRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$7.57M Buy
279,071
+204,231
+273% +$5.21M ﹤0.01% 2561
2016
Q3 		$1.92M Buy
74,840
+3,910
+6% +$83K ﹤0.01% 3070
2016
Q2 		$1.31M Buy
70,930
+42,644
+151% +$845K ﹤0.01% 3215
2016
Q1 		$536K Buy
28,286
+5,535
+24% +$106K ﹤0.01% 3446
2015
Q4 		$613K Buy
+22,751
New +$443K ﹤0.01% 3461

Other funds holding ACRS

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
SMV
Sofinnova Management VIII Menlo Park, California $183M AUM 4.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock Institutional Trust's ACRS Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Aclaris Therapeutics (ACRS) stake by 273% in Q4 2016, buying an estimated $5.21M and bringing the position to 279,071 shares worth $7.57M. The position accounts for ﹤0.01% of the portfolio, ranked #2561.

BlackRock Institutional Trust first reported a position in ACRS in Q4 2015 and has held it in 5 quarters since. 100 funds tracked by Wall St. Rank hold ACRS as of Q4 2016.

  • BlackRock Institutional Trust held 279,071 shares of Aclaris Therapeutics worth $7.57M as of Q4 2016.
  • BlackRock Institutional Trust bought 204,231 Aclaris Therapeutics shares in Q4 2016, an estimated $5.21M.
  • Aclaris Therapeutics made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2561 holding.
  • BlackRock Institutional Trust first reported a position in Aclaris Therapeutics in Q4 2015 and has held it in 5 quarters since.
  • 100 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.